icon-folder.gif   Conference Reports for NATAP  
 
  AASLD
60th Annual Meeting of the American Association for the Study of Liver Diseases
Boston, MA, Hynes Convention Center
October 30-November 3, 2009
Back grey_arrow_rt.gif
 
 
 
Physician Country of Birth and Hepatitis B Virus (HBV) Screening Practices of Asian-American Primary Care Providers (PCPs) Who Treat Asian Adults Living in the US
 
 
  Reported by Jules Levin
AASLD Nov 3 2009 Boston
 
T Tran1, ASF Lok2, D Goodwin3, D Chu4, WR Kim5, R Fisher3, D Coombs3, EA Fagan3, F Rousseau3 1Geffen UCLA School of Medicine, Cedars Sinai Medical Center, Los Angeles, CA, USA; 2University of Michigan Medical Center, Ann Arbor, MI, USA; 3Gilead Sciences, Inc., Foster City, CA, USA; 4Albert Einstein College of Medicine, New York, NY, USA; 5Mayo Clinic College of Medicine, Rochester, MN, USA

image002.gif

BACKGROUND
 
Chronic HBV infection (CHB) disproportionately affects Asian-Americans
- Prevalence of ≥ 10%
- Incidence > 2 times that of Caucasian-Americans
 
Hepatocellular carcinoma (HCC) in Asian- Americans
- Risk is 2.7 times higher than in Caucasian-Americans
- Second highest cause of cancer mortality in Asian-American men
- Five-year survival rate is < 10%
 
Fewer than 25% of Asian-American patients with CHB have been diagnosed
 
40-60% of Asian-Americans with CHB go unscreened
 
OBJECTIVES
 
To determine the percentage of Asian patients living in the US screened for HBV infection by Asian-American primary care providers (PCPs)
 
To survey HBV screening practices of Asian-American PCPs, including barriers and motivators for screening
 
To determine if there are differences in HBV screening practices among Asian-American PCPs according to their country of birth

image004.gif

image006.gif

RESULTS
 

image008.gif

image010.gif

image012.gif

image014.gif

image016.gif

image018.gif

image020.gif

image022.gif

image024.gif